Process for treatment of diseases

Details Process for treatment of diseases Process for treatment of diseases

1990-04-18

1992-09-08

Cashion, Jr., Merrell C.

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

424 852, 424 851, A61K 3766

Patent

active

051456770

ABSTRACT:
This invention relates to the treatment of various diseases such as such as those characterized by tumorigenic or neoplastic cell growth, malignant hematological systemic diseases, viral diseases, carcinomas, sarcomas, myelomas, melanomas, lymphomas, papillomas, degenerative diseases, allergic diseases, asthma, psoriasis and pain. More particularly, this invention relates to processes and compositions for treating these diseases by administering to a patient a pharmaceutically effective low dose amount of gamma interferon.

REFERENCES:
patent: 4460574 (1984-07-01), Yabrov
patent: 4727138 (1988-02-01), Goeddel
patent: 4840032 (1984-10-01), Yabrov
patent: 4946674 (1990-08-01), von Eichborn et al.
C. W. Czarniecki et al., "Synergistic Antiviral and Antiproliferative Activities of Escherichia coli--Derived Human Alpha, Beta and Gamma Interferons", J. Virol., 49, pp. 490-496 (1984).
H. A. Harvey et al., "A Phase I Trial of Gamma Interferon (Hu-IFN-.gamma.) in Advanced Malignancy", Proc. Am. Soc. Clin. Oncol., 2, p. 46, (Abstract C-179), (1983).
S. J. Mora et al., "Observations on the Use of Intrathecal Interferon (IT-IFN)", Neurology, 34, (Suppl. 1), p. 141, (Abstract PP70), (1984).
K. Osther et al., "Human Gamma Interferon Phase I and Phase II Trails", Proc. Am. Soc. Oncol., 2, p. 47 (1983).
K. Osther et al., "Phase I and Phase II Trails With Human Gamma Interferon", The Biology of the Interferon System, pp. 527-533 (1983).
G. Sonnenfeld, "Effects of Interferon on Antibody Formation", in Interferon, Volume 2: Interferons and the Immune System, J. Vilcek and E. De Maeyers, eds., Elsevier Amsterdam, pp. 95-99 (1984).
D. A. Weigent et al., "Potentiation of Lymphocyte Natural Killing Mixtures of Alpha or Beta Interferon with Recombinant Gamma Interferon", Infection and Immunity, 40, pp. 35-38 (1983).
R. Kurzrock et al., "Pharmacokinetics, Single Dose Tolerance and Biological Activity of Recombinant Gamma Interferon in Cancer Patients", Cancer Res., 45, pp. 4167-4171 (1984).
A. Munoz et al., "Comparison of the Antiviral Action of Different Human Interferons Against DNA and RNA Viruses", FEMS Micro. Lett., 21, pp. 105-111 (1984).
Niederle et al., "Phase I Study of Recombinant Human Interferon Gamma (rIFN-(gamma)) in Patients with Advanced Cancer", Biology of the Interferon System, p. 31 (1984).
M. Ogawa et al., "A Phase I Trail of Recombinant Interferon", Proc. Am. Soc. Clin. Oncol., 4, p. 219 (1985).
van der Berg et al., "Recombinant--(gamma) (Immunneron): Results of a Phase I Trail in Patients with Cancer", J. Biol. Resp. Mod., 4, pp. 264-272 (1985).
Gutterman et al., Cancer Research, 44, pp. 4164-4171, Sep. 1984.

Affiliated with

Also associated with

Rating

Process for treatment of diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for treatment of diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treatment of diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-133008